Literature DB >> 31811415

Placental protein expression of kisspeptin-1 (KISS1) and the kisspeptin-1 receptor (KISS1R) in pregnancy complicated by diabetes mellitus or preeclampsia.

R V Kapustin1, A O Drobintseva2, E N Alekseenkova2, A R Onopriychuk2, O N Arzhanova2, V O Polyakova2, I M Kvetnoy2.   

Abstract

PURPOSE: Kisspeptins regulate the trophoblast invasion. The disturbance of this process might lead to the development of preeclampsia (PE). Diabetes mellitus (DM) is associated with the high rate of this complication. The main hypothesis was to investigate the placental protein expression of kisspeptin-1 (KISS1) and its receptor (KISS1R) in diabetic, preeclamptic, and healthy pregnancies.
METHODS: Placentae (n = 65) were divided into the following groups: the control group (n = 20), either PE or non-PE type-1 diabetes mellitus (T1DM) (n = 10), either PE or non-PE type-2 diabetes mellitus (T2DM) (n = 10), either PE or non-PE gestational diabetes mellitus (GDM) (n = 10) and preeclampsia without diabetes (PE) (n = 15). Immunohistochemistry analysis was used for demonstrating the presence and location of KISS1/KISS1R in placental tissue and to measure the area of immunopositive expression. Correlation analyses were performed to detect the links between protein expression of these biomarkers and the main obstetric outcomes.
RESULTS: The highest placental protein expressions of KISS1 were detected in the PE (35.4%) and GDM (33.2%) groups. In case of DM, levels of KISS1 expression depended on the presence of PE and were higher compared with DM no PE and control groups: (30.6%) in T1DM + PE and (30.1%) in T2DM + PE group. The lowest expression was detected in the control group (14.1%). The expression of KISS1R was higher in DM and PE compared to the control group. We detected the strong direct link between PE and placental expression of KISS1 (r = 0.81) and KISS1R (r = 0.56), and inverse correlation link between KISS1 and preterm birth weight (r = - 0.73). The low correlation links were found between KISS1 and IUGR (r = 0.29), and preterm birth (r = 0.24). The same trend was detected for KISS1R. We did not find any significant correlations between placental expressions of KISS/KISS1R and placental weight or HbA1c levels.
CONCLUSION: Increased expression levels of KISS1 and KISS1R in case of diabetes mellitus may play a role in the altered placentation process and lead to the development of preeclampsia.

Entities:  

Keywords:  Gestational diabetes; Kisspeptins; Placenta; Pre-gestational diabetes; Preeclampsia

Year:  2019        PMID: 31811415     DOI: 10.1007/s00404-019-05408-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  10 in total

Review 1.  The Role of Kisspeptin in the Pathogenesis of Pregnancy Complications: A Narrative Review.

Authors:  Magdalena Szydełko-Gorzkowicz; Elżbieta Poniedziałek-Czajkowska; Radzisław Mierzyński; Maciej Sotowski; Bożena Leszczyńska-Gorzelak
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

2.  Tai Chi Program to Improve Glucose Control and Quality of Life for the Elderly With Type 2 Diabetes: A Meta-analysis.

Authors:  Yanmei Wang; Jianjun Yan; Peng Zhang; Pei Yang; Wenhui Zhang; Min Lu
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 2.099

3.  EGF stimulates human trophoblast cell invasion by downregulating ID3-mediated KISS1 expression.

Authors:  Lanlan Fang; Yibo Gao; Zhen Wang; Yuxi Li; Yang Yan; Ze Wu; Jung-Chien Cheng; Ying-Pu Sun
Journal:  Cell Commun Signal       Date:  2021-10-07       Impact factor: 5.712

Review 4.  Kisspeptin in the Prediction of Pregnancy Complications.

Authors:  Jovanna Tsoutsouki; Bijal Patel; Alexander N Comninos; Waljit S Dhillo; Ali Abbara
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-19       Impact factor: 6.055

5.  Kisspeptin treatment improves fetal-placental development and blocks placental oxidative damage caused by maternal hypothyroidism in an experimental rat model.

Authors:  Bianca Reis Santos; Jeane Martinha Dos Anjos Cordeiro; Luciano Cardoso Santos; Erikles Macedo Barbosa; Letícia Dias Mendonça; Emilly Oliveira Santos; Isabella Oliveira de Macedo; Mário Sergio Lima de Lavor; Raphael Escorsim Szawka; Rogeria Serakides; Juneo Freitas Silva
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

Review 6.  Kisspeptins and Glucose Homeostasis in Pregnancy: Implications for Gestational Diabetes Mellitus-a Review Article.

Authors:  Ezekiel Musa; Mushi Matjila; Naomi S Levitt
Journal:  Reprod Sci       Date:  2021-01-04       Impact factor: 3.060

Review 7.  Pharmacogenetics of Type 2 Diabetes-Progress and Prospects.

Authors:  Yulia A Nasykhova; Ziravard N Tonyan; Anastasiia A Mikhailova; Maria M Danilova; Andrey S Glotov
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

8.  Changes in Circulating Kisspeptin Levels During Each Trimester in Women With Antenatal Complications.

Authors:  Ali Abbara; Maya Al-Memar; Maria Phylactou; Elisabeth Daniels; Bijal Patel; Pei C Eng; Rans Nadir; Chioma Izzi-Engbeaya; Sophie A Clarke; Edouard G Mills; Tia Hunjan; Ewa Pacuszka; Lisa Yang; Paul Bech; Tricia Tan; Alexander N Comninos; Tom W Kelsey; Christopher Kyriacou; Hanine Fourie; Tom Bourne; Waljit S Dhillo
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 5.958

9.  TGF-β1 inhibits human trophoblast cell invasion by upregulating kisspeptin expression through ERK1/2 but not SMAD signaling pathway.

Authors:  Lanlan Fang; Yang Yan; Yibo Gao; Ze Wu; Zhen Wang; Sizhu Yang; Jung-Chien Cheng; Ying-Pu Sun
Journal:  Reprod Biol Endocrinol       Date:  2022-01-31       Impact factor: 5.211

10.  Transcriptomic analysis of primate placentas and novel rhesus trophoblast cell lines informs investigations of human placentation.

Authors:  Jimi L Rosenkrantz; Jessica E Gaffney; Victoria H J Roberts; Lucia Carbone; Shawn L Chavez
Journal:  BMC Biol       Date:  2021-06-21       Impact factor: 7.431

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.